Hyperlipidaemia Flashcards
1
Q
Atorvastatin
A
- competitive inhibitor of HMG-CoA reductase (rate controlling enzyme in mevalonate pathway)
- upregulation of hepatic LDL receptors
- increased clearance of circulating LDL
- first line therapy for cholesterol
- has a long half life and goes through first pass metabolism (active derivatives)
- side effects: GI disruption, nausea, headache, muscle pain (will see increased CPK), rhabdomyolysis (very rare)
- contraindication: renal impairment, pregnancy, breastfeeding, using antibiotics (macrolides) or amlodipine, amiodarone, diltiazem,
- primary prevention: 20mg once daily
- secondary prevention: 80mg once daily
- taken orally
2
Q
Simvastatin
A
- first line statin
- prodrug activated by first pass metabolism
- short half-life so should take just before bedtime because of circadian rhythm and cholesterol cycle as well
- side effects: GI disruption, nausea, headache, myalgia
- contraindications: renal impairment, pregnancy, breastfeeding, antibiotics, (same as atorvastatin)
- oral
- check liver function, CK, and diabetes before treatment
3
Q
Fluvastatin
A
- used to treat high cholesterol in adults and children of at least 10
- same side effects and contraindications as other statins
- Dont take: liver problems, pregnant, breastfeeding
- hydrophilic so will cause less insomnia
- does not require dosage adjustment in patients with renal impairment
- is metabolised by the CYP2C9
4
Q
Pravastatin
A
- first pass metabolism doesnt occur with this one
- least protein-bound of the statins
- hydrophilic so will cause less insomnia
- greater renal elimination
5
Q
Rosuvastatin
A
- better at lowering LDLs (right after atorvastatin)
- very few negative interactions with other drugs
- hydrophilic
- may have diabetic side effects
6
Q
Lovastatin
A
-food increases the bioavailability of this statin
7
Q
Cerivastatin
A
- withdrawn
- is a fibrates
- caused some deaths through rhabdomyolysis and renal failure
8
Q
Fenofibrate
A
- is a fabric acid derivative (fibrates)
- oral
- activates nuclear transcription factor (PPARa)
- promotes gene expression in nucleus to increase lipoprotein lipase
- usually used as an adjunct with statins when the statins are contraindicated
- increases triglyceride metabolism, fatty acid uptake by liver, HDL levels, and LDL affinity for receptor
- side effects: gallstones, flatulence, myositis
- contraindication: warfarin as it will increase bleeding risk
- do not give to patients with hypothyroidism
9
Q
Ezetimibe
A
- cholesterol absorption inhibitor
- inhibits NPC1L1 transporter at the brush border of the intestines
- usually co-prescribed with statins
- reduces absorption of cholesterol in the gut
- hepatic LDL receptor expression increases
- decreases total cholesterol by 15% and LDL by 20%
- is a prodrug which means it needs hepatic metabolism and it limits systemic exposure
- side effect: abd pain, GI upset, diarrhoea
- contraindication: hepatic failure
10
Q
Alirocumab
A
- monoclonal antibodies
- PCSK9 inhibitors
- PCSK9 usually internalizes LDL with receptor for degradation
- inhibitor allows more LDL recruitment without the receptor
- subcutaneous injection
- side effects: nasal, pulmonary, skin reactions
11
Q
Evolocumab
A
- PCSK9 inhibitor
- for hypercholesterolaemia
- subcutaneous injection
- side effects: back pain, nausea, arthralgia
- contraindication: renal impairment
12
Q
What food options are there to lower cholesterol?
A
- plant sterols
- fish oils
- fibre
- vitamin C/E
- NO to alcohol even though it increases HDL, it also increases triglycerides
13
Q
What are the benefits of statin therapy?
A
- main: reduce CVD risk
- improves vascular endothelial function
- stabilization of atherosclerotic plaque
- improved haemostasis
- anti-inflammatory: decrease in proliferation of inflammatory cells into plaque
- antioxidant: superoxide formation